Buy Sun Pharma, says Shardul Kulkarni

Shardul Kulkarni of Angel Broking told CNBC-TV18, "The chart structure of Sun Pharmaceutical Industries clearly shows a good strong breakout in today's trading session. I have picked two defensive counters, one is Sun Pharma and the other is Asian Paints."

"The high beta stocks don’t have volume participation whereas these two counters, Sun Pharma as well as Asian Paints have decent volume contribution. Going forward the breakout will last over the next couple of days. So, Sun Pharma would be a buy. The stoploss would be at Rs 565 on the lower side and I think that Rs 615-620 can be expected in Sun Pharma," he said.

Disclosure: He may have recommended the stock to his clients and they may have taken them in their portfolios.